Company Update ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Alembic Pharmaceuticals receives USFDA Final Approval for Brexpiprazole Tablets, 0.25mg, 0.5 mg, 1 mg, 2 mg, 3mg and 4 mg.